Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay

Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay

Background: Lipoprotein particles with abnormal compositions, such as lipoprotein X (LP-X) and lipoprotein Z (LP-Z), have been described in cases of obstructive jaundice and cholestasis. The study objectives were to: (1) develop an NMR-based assay for quantification of plasma/serum LP-Z particles, (...

Full description

Bibliographic Details
Main Authors: Shimpi Bedi, Erwin Garcia, Elias J. Jeyarajah, Irina Shalaurova, Maria Camila Perez-Matos, Z. Gordon Jiang, Robin P. F. Dullaart, Steven P. Matyus, William J. Kirk, James D. Otvos, W. Sean Davidson, Margery A. Connelly
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
lipoproteins
nuclear magnetic resonance spectroscopy
cholestasis
liver disease
Online Access:https://www.mdpi.com/2077-0383/9/9/2915

Similar Items

Similar Items